Ghana becomes the first in the world to approve a new malaria vaccine developed by Oxford University.

This breakthrough vaccine is expected to benefit children under the age of three years old who are at high risk of contracting the mosquito-borne disease.

Malaria claims the lives of over 600,000 people annually, with the majority being children in Africa, and scientists have been working for years to develop effective vaccines.

However, it remains unclear when the Oxford vaccine will be made available in the country.

James Adjapong tells us more.